Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
506.00    -6.00 (-1.17%)
Bid:
506.00
Ask:
510.00
Spread: 4.00 (0.791%)
Market Cap: £835.99m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Portfolio Update

1 Jul 2009 12:30

RNS Number : 9121U
Oakley Capital Investments Limited
01 July 2009
Β 

ο»Ώ

01 July 2009

Oakley Capital Investments LimitedΒ ("OCIL")

("the Company")

Portfolio Update

Divestment of Vialtus Solutions

Oakley Capital Investments Limited (AIM: OCL, "OCIL"), the AIM-listed company established to provide investors with access to the investment strategy being pursued by Oakley Capital Private Equity L.P. (the "Limited Partnership"Β or the "Fund"),Β announcesΒ that theΒ Limited Partnership'sΒ largest portfolio company, Host EuropeΒ Corporation Limited ("Host Europe"), has conditionally sold one of its three operating divisions,Β "Vialtus Solutions"Β for Β£42 millionΒ to Freedom4 Group plcΒ ("Freedom4"), which has announced its intention to change its name to Daisy Group plc ("Daisy"). The sale of Vialtus Solutions, which is subject toΒ Freedom4Β shareholder approvalΒ at an EGM to be convened on 20 July 2009, is expected to be completed within three weeks. Β£13 million of theΒ considerationΒ is to be settled in cash and the remaining Β£29 million in Ordinary Shares inΒ Freedom4. HostΒ EuropeΒ will receive under the proposalsΒ 36,250,000 Freedom4 ordinary shares (following a share consolidation on a 1 for 20 basis)Β at Β£0.80 per share.

Further announcements will be made in due course.Β 

For further information please contact:Β 

Β 

Oakley Capital Investments Limited

+44Β 20 7766 6900

Peter DubensΒ (Director)

Financial Dynamics

+44Β 20 7831 3113

Juliet Clarke / Edward Bridges / Erwan Gouraud

Liberum CapitalΒ LimitedΒ (Financial Adviser & Broker)

+44Β 20Β 3100 2000

Steven Tredget / Steve Pearce

Grant ThorntonΒ Capital MarketsΒ (Nominated Adviser)

+44Β 20Β 7383 5100

Philip SecrettΒ 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
PFUFFLFBKDBLBBD
Date   Source Headline
18th Mar 20247:00 amRNSOakley Capital invests in Horizons Optical
15th Mar 20244:00 pmRNSQuotedData's Weekly News & Interview
14th Mar 20245:32 pmRNSDividend Declaration
14th Mar 20247:00 amRNSAnnual Results 2023
4th Mar 20247:00 amRNSNotice of Results and Investor Presentation
15th Feb 20247:00 amRNSAppointment of Financial Adviser
13th Feb 20247:00 amRNSDirector Dealing
13th Feb 20247:00 amRNSDirector Dealing
24th Jan 20247:00 amRNSTrading Statement
16th Jan 20247:00 amRNSOakley agrees investment in Steer Automotive Group
15th Jan 20247:00 amRNSHolding(s) in Company
29th Dec 20237:00 amRNSSettlement of Fund I Loan
20th Dec 20239:39 amRNSUpdate from QuotedData
20th Dec 20237:00 amRNSHolding(s) in Company
28th Nov 20232:39 pmRNSResult of AGM
21st Nov 20237:00 amRNSDirector Dealing
7th Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
30th Oct 20237:00 amRNSNotice of AGM and Directorate Change
30th Oct 20237:00 amRNSInvestment in Alerce
26th Oct 202311:14 amRNSInvestment in Webcentral
25th Oct 20237:00 amRNSTrading update for the 3 months ended 30 Sep 2023
18th Oct 20237:00 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSHolding(s) in Company
14th Sep 20235:53 pmRNSInterim Results 2023 - Replacement
14th Sep 20237:00 amRNSInterim Results for the 6 months ended 30 June 23
30th Aug 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSOakley invests in three dental labs businesses
31st Jul 202312:14 pmRNSDirector Dealing
28th Jul 20232:27 pmRNSDirector Dealing
26th Jul 20237:00 amRNSTrading update for the 6 months ended 30 June 2023
26th Jun 20237:00 amRNSDirector Dealing
26th Jun 20237:00 amRNSDirector Dealing
19th Jun 202311:44 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
17th May 20238:04 amRNSOakley Capital extends IU Group partnership
10th May 20237:00 amRNSSale and Reinvestment in IU Group
26th Apr 20237:00 amRNSTrading update for the 3 months ended 31 Mar 2023
18th Apr 20237:00 amRNSOakley partners with schools group Thomas's
4th Apr 20231:13 pmRNSInitiation from QuotedData
31st Mar 20238:00 amEQSHardman & Co Q&A on Oakley Capital Investments (OCI): 2022 Results: EBITDA Growth Drives NAV Appreciation
16th Mar 20237:00 amRNSDirector Dealing
15th Mar 20237:15 amEQSHardman & Co Research on Oakley Capital Investments Ltd (OCI): 2022: NAV returns driven by EBITDA growth
9th Mar 20237:00 amRNSFinal Results for the Year Ended 31 December 2022
27th Feb 20237:00 amRNSNotice of Results and Investor Presentation
25th Jan 20237:00 amRNSTrading update for the year ended 31 December 2022
18th Jan 20234:19 pmRNSHolding(s) in Company
18th Jan 20234:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.